HEP DART 2003: Frontiers in Drug Development for Viral Hepatitis

Author： Raney Anneke K Hamatake Robert K Hong Zhi

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.3, 2004-03, pp. : 289-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretroviral drugs in development. A report from HIV DART 2008: frontiers in drug development for antiretroviral therapies

By Temesgen Zelalem

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 549-553

Informa Healthcare

Access to resources Recommend Favorite

Drugs in Development for Viral Hepatitis: Care and Caution

By Pockros Paul J.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 263-271

Adis International

Access to resources Recommend Favorite

Bicyclol: A Novel Drug for Treating Chronic Viral Hepatitis B and C

Medicinal Chemistry, Vol. 5, Iss. 1, 2009-01 ,pp. : 29-43

Bentham Science Publishers

Access to resources Recommend Favorite

New Strategies for Immune-Mediated Anti-Viral Drug and Vaccine Development

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1391-1401

Bentham Science Publishers

Access to resources Recommend Favorite

New Vector Innovation for Drug Delivery: Development of Fusigenic Non- Viral Particles

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 599-602

Bentham Science Publishers

Access to resources Recommend Favorite